Biocon Limited
NSE:BIOCON.NS
Overview | Financials
Company Name | Biocon Limited |
Symbol | BIOCON.NS |
Currency | INR |
Price | 321.3 |
Market Cap | 385,752,780,000 |
Dividend Yield | 0.48% |
52-week-range | 222.55 - 395.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Siddharth Mittal BCom, CA, CPA |
Website | https://www.biocon.com |
An error occurred while fetching data.
About Biocon Limited
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD